LENS-PHARM, LLC ,   Russia

inhibitor of proteolysis.

Solution for infusions 10 000 KIE / ml.

Proteolysis inhibitor

Lyophilizate for the preparation of a solution for intravenous administration of 10,000 ATPE and 100,000 ATPE.

Antitumor agent - enzyme

Liofilizate for the preparation of a solution for intravenous and intramuscular injection of 10,000 ME in glass bottles.

Antitumor agent - antibiotic
Liofilizate for the preparation of solution for injection, 5 mg and 15 mg.
Antitumour agent, antimetabolite
Lyophilizate for the preparation of solution for injection 500 mg and 1000 mg.
Antitumour agent, antimetabolite
Solution for injection 5 mg / ml (5 mg / 1 ml, 10 mg / 2 ml) and 10 mg / ml (50 mg / 5 ml).
Antitumor agent - alkaloid
Lyophilizate for the preparation of a solution for intravenous administration, 5 mg.
Antitumour agent, antimetabolite
Lyophilizate for the preparation of a solution for infusions of 200 mg and 1000 mg.
Hepatoprotective agent
Lyophilizate for the preparation of solution for intravenous and intramuscular injection 400 mg.

Solvent on 5 ml.

Antitumor agent, antibiotic.

Solution for intravascular and intravesical administration 2 mg / ml (10 mg / 5 ml, 25 mg / 12.5 ml, 50 mg / 25 ml, 75 mg / 37.5 ml or 150 mg / 75 ml).

Antitumor agent, antibiotic.
Lyophilizate for solution preparation for intravascular and intravesical administration
in vials of 10 mg and 50 mg.

Antitumor agent - alkaloid

Concentrate for solution for infusion, 20 mg / ml.

An antitumour agent, an alkylating compound

Concentrate for the preparation of a solution for infusions of 10 mg / ml.

Nondepolarizing muscle relaxant of peripheral action.
Solution for intravenous administration 10 mg / ml (50 mg / 5 ml, 100 mg / 10 ml).
anticonvulsant - alpha-adrenomimetic
nasal spray 0.05%
Antidote antagonists of folic acid; modifier of biological action of fluorouracil
A solution for intravenous and intramuscular administration of 5 mg / ml (10 mg / 2 ml, 25 mg / 5 ml, 50 mg / 10 ml) or 10 mg / ml (ZOMg / Zml, 50 mg / 5 ml, 100 mg / 10 ml ).
Antidote antagonists of folic acid; modifier of biological action of fluorouracil
Lyophilizate for the preparation of a solution for intravenous and intramuscular administration, 10 mg, 25 mg, 30 mg and 50 mg.
Antitumor agent, alkaloid

Concentrate for the preparation of a solution for infusions of 10 mg / ml (10 mg / ml, 35 mg / 3.5 ml and 50 mg / 5 ml).

Progestogen
Suspension for intramuscular injection of 500 mg / 3.3 ml and 1000 mg / 6.7 ml (150 mg / ml).
Leukopoiesis stimulant

A solution for intravenous and subcutaneous administration of 30 million IU / mL (15 million IU / 0.5 mL, 30 million IU / 1 mL, 48 million IU / 1.6 mL, 75 million IU / 2.5 mL).

Antiemetic means - serotonin receptor antagonist

Solution for intravenous and intramuscular injection, 2 mg / ml.

antitumor agent - alkaloid
Concentrate for the preparation of a solution for infusion 6 mg / ml (30 mg / 5 ml 100 mg / 17 ml, 120 mg / 20 ml, 140 mg / 23.3 ml, 150 mg / 25 ml, 210 mg / 35 ml 250 mg / 41.7 ml, 260 mg / 43.4 ml, 276 mg / 46 ml, 300 mg / 50 ml).
immunostimulating agent

Lyophilizate for solution for injection, 100 units.

immunostimulating agent
Nasal drops, 50 U / ml.
immunostimulating agent

Liofilizate for the preparation of nasal drops, 100 units.

immunostimulating agent

Lyophilizate for the preparation of eye drops, 100 units.

antitumor agent, antibiotic
Lyophilizate for the preparation of a solution for intravenous administration in vials of 5 mg.
laxative

Drops for oral administration 7.5 mg / ml. For 15 ml in bottles of lightproof glass with a stopper dropper. For 30 ml in bottles of light-protective glass complete with a dropper. Each bottle, together with the instructions for use, is placed in a pack of cardboard.

antibiotic-macrolide
Liofilizate for the preparation of a solution for intravenous administration of 1.5 million ME. For 1.5 million ME of active substance in the bottles of colorless glass, hermetically sealed with stoppers made of rubber compound, with the capping of aluminum caps.Each vial with instructions for use is placed in a pack of cardboard.

antitumor agent - alkaloid

Concentrate for solution for infusion, 20 mg / ml.

Antiglaucoma means β-blocker.
Eye drops 0.25% and 0.5%.
5 ml or 10 ml in bottles of neutral glass or imported I or II hydrolytic class, hermetically sealed with rubber stoppers, crimped with aluminum caps. By 5 ml or 10 ml in the bottles-droppers made of polymer materials.
1 glass bottle or a dropper with instructions for use are placed in a pack of cardboard. 1 glass bottle with instruction for use complete with a lid-dropper polyethylene placed in a pack of cardboard.

70 glass bottles or flasks-droppers with an equal number of instructions for use are placed in a box (for hospitals).


antiemetics - serotonin receptor antagonist
Solution for intravenous administration.
Antifungal agent.
Solution for infusions 2 mg / ml.
antitumour agent, antimetabolite
Solution for intravascular injection 50 mg / ml
luteinizing agent

Lyophilizate for solution for intramuscular injection, 1500 ME or 5000 ME.

An antitumour agent, an alkylating compound.

Lyophilizate for the preparation of a solution for intravenous and intramuscular injection in vials of 100 mg and 200 mg.

antitumor agent - alkylating compound

Concentrate for solution for infusion, 0.5 mg / ml.

antitumour agent - antimetabolite

Liofilizate for the preparation of solution for injection, 100 mg.

antitumor agent - alkylating compound
Liofilizate for solution for infusion 50 mg, 100 mg in bottles of colorless glass.
antitumor agent - alkylating compound

Lyophilizate for the preparation of a solution for infusions of 150 mg in bottles of colorless glass.

antitumor agent, alkaloid.

Concentrate for the preparation of a solution for infusions of 20 mg / ml (50 mg / 2.5 ml, 100 mg / 5 ml, 200 mg / 10 ml).